Literature DB >> 16818604

BRCA1 ubiquitinates its phosphorylation-dependent binding partner CtIP.

Xiaochun Yu1, Shuang Fu, Maoyi Lai, Richard Baer, Junjie Chen.   

Abstract

BRCA1 (Breast Cancer Susceptibility Gene 1) possesses an N-terminal Ring domain and tandem C-terminal BRCT motifs. While the Ring domain has E3 ubiquitin ligase activity, the BRCA1 BRCT domains specifically recognize phospho-serine motifs. Here, we demonstrate that BRCA1 Ring domain catalyzes CtIP ubiquitination in a manner that depends on a phosphorylation-mediated interaction between CtIP and BRCA1 BRCT domains. The BRCA1-dependent ubiquitination of CtIP does not target CtIP for degradation. Instead, ubiquitinated CtIP associates with chromatin following DNA damage and participates in G2/M checkpoint control. Thus, we propose that BRCA1 can regulate the functions of its substrates through nonproteasomal pathways that do not involve substrate degradation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16818604      PMCID: PMC1522068          DOI: 10.1101/gad.1431006

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  33 in total

1.  RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination.

Authors:  K L Lorick; J P Jensen; S Fang; A M Ong; S Hatakeyama; A M Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

2.  BRCA1-dependent ubiquitination of gamma-tubulin regulates centrosome number.

Authors:  Lea M Starita; Yuka Machida; Satish Sankaran; Joshua E Elias; Karen Griffin; Brian P Schlegel; Steven P Gygi; Jeffrey D Parvin
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

3.  DNA damage-induced cell cycle checkpoint control requires CtIP, a phosphorylation-dependent binding partner of BRCA1 C-terminal domains.

Authors:  Xiaochun Yu; Junjie Chen
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

Review 4.  Interactions between BRCT repeats and phosphoproteins: tangled up in two.

Authors:  J N Mark Glover; R Scott Williams; Megan S Lee
Journal:  Trends Biochem Sci       Date:  2004-11       Impact factor: 13.807

5.  Characterization of a carboxy-terminal BRCA1 interacting protein.

Authors:  A K Wong; P A Ormonde; R Pero; Y Chen; L Lian; G Salada; S Berry; Q Lawrence; P Dayananth; P Ha; S V Tavtigian; D H Teng; P L Bartel
Journal:  Oncogene       Date:  1998-11-05       Impact factor: 9.867

6.  The C-terminal (BRCT) domains of BRCA1 interact in vivo with CtIP, a protein implicated in the CtBP pathway of transcriptional repression.

Authors:  X Yu; L C Wu; A M Bowcock; A Aronheim; R Baer
Journal:  J Biol Chem       Date:  1998-09-25       Impact factor: 5.157

7.  Regulated interaction of the Fanconi anemia protein, FANCD2, with chromatin.

Authors:  Rocio Montes de Oca; Paul R Andreassen; Steven P Margossian; Richard C Gregory; Toshiyasu Taniguchi; Xiaozhe Wang; Scott Houghtaling; Markus Grompe; Alan D D'Andrea
Journal:  Blood       Date:  2004-09-28       Impact factor: 22.113

8.  BRCT repeats as phosphopeptide-binding modules involved in protein targeting.

Authors:  Isaac A Manke; Drew M Lowery; Anhco Nguyen; Michael B Yaffe
Journal:  Science       Date:  2003-10-24       Impact factor: 47.728

9.  The BRCA1/BARD1 heterodimer assembles polyubiquitin chains through an unconventional linkage involving lysine residue K6 of ubiquitin.

Authors:  Foon Wu-Baer; Karen Lagrazon; Wei Yuan; Richard Baer
Journal:  J Biol Chem       Date:  2003-07-30       Impact factor: 5.157

10.  Characterization of a breast cancer cell line derived from a germ-line BRCA1 mutation carrier.

Authors:  G E Tomlinson; T T Chen; V A Stastny; A K Virmani; M A Spillman; V Tonk; J L Blum; N R Schneider; I I Wistuba; J W Shay; J D Minna; A F Gazdar
Journal:  Cancer Res       Date:  1998-08-01       Impact factor: 12.701

View more
  140 in total

1.  BRCA1 tumor suppression depends on BRCT phosphoprotein binding, but not its E3 ligase activity.

Authors:  Reena Shakya; Latarsha J Reid; Colleen R Reczek; Francesca Cole; Dieter Egli; Chyuan-Sheng Lin; Dirk G deRooij; Steffen Hirsch; Kandasamy Ravi; James B Hicks; Matthias Szabolcs; Maria Jasin; Richard Baer; Thomas Ludwig
Journal:  Science       Date:  2011-10-28       Impact factor: 47.728

Review 2.  BRCA1-directed, enhanced and aberrant homologous recombination: mechanism and potential treatment strategies.

Authors:  Seth M Dever; E Railey White; Matthew C T Hartman; Kristoffer Valerie
Journal:  Cell Cycle       Date:  2012-02-15       Impact factor: 4.534

3.  Initiation of DNA double strand break repair: signaling and single-stranded resection dictate the choice between homologous recombination, non-homologous end-joining and alternative end-joining.

Authors:  Anastazja Grabarz; Aurélia Barascu; Josée Guirouilh-Barbat; Bernard S Lopez
Journal:  Am J Cancer Res       Date:  2012-04-21       Impact factor: 6.166

4.  DNA repair: Decision at the break point.

Authors:  Simon J Boulton
Journal:  Nature       Date:  2010-05-20       Impact factor: 49.962

5.  The UBXN1 protein associates with autoubiquitinated forms of the BRCA1 tumor suppressor and inhibits its enzymatic function.

Authors:  Foon Wu-Baer; Thomas Ludwig; Richard Baer
Journal:  Mol Cell Biol       Date:  2010-03-29       Impact factor: 4.272

Review 6.  Ubiquitin signalling in DNA replication and repair.

Authors:  Helle D Ulrich; Helen Walden
Journal:  Nat Rev Mol Cell Biol       Date:  2010-06-16       Impact factor: 94.444

7.  Quantitative proteomic identification of the BRCA1 ubiquitination substrates.

Authors:  Meihua Song; Kevin Hakala; Susan T Weintraub; Yuzuru Shiio
Journal:  J Proteome Res       Date:  2011-10-11       Impact factor: 4.466

8.  The Histone Variant MacroH2A1 Is a BRCA1 Ubiquitin Ligase Substrate.

Authors:  Beom-Jun Kim; Doug W Chan; Sung Yun Jung; Yue Chen; Jun Qin; Yi Wang
Journal:  Cell Rep       Date:  2017-05-30       Impact factor: 9.423

9.  CtIP mediates replication fork recovery in a FANCD2-regulated manner.

Authors:  Jung Eun Yeo; Eu Han Lee; Eric A Hendrickson; Alexandra Sobeck
Journal:  Hum Mol Genet       Date:  2014-02-20       Impact factor: 6.150

Review 10.  53BP1: pro choice in DNA repair.

Authors:  Michal Zimmermann; Titia de Lange
Journal:  Trends Cell Biol       Date:  2013-10-04       Impact factor: 20.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.